Keywords: fujisawa, says, micafungin, delayed, approval, its, new

Fujisawa says US entry of micafungin delayed

Article | 10 February 2003

Print This

Fujisawa says that US approval of its new antifungal drug micafunginsodium will be delayed from the firm's target of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in